1122400-35-4

Upstream product

• 1122400-34-3 4-bromo-N-(4-(tert-butyl)phenyl)-N-(p-tolyl)aniline 
• 54663-78-4 tributyl(thien-2-yl)stannane 
• 6165-68-0 thiophene boronic acid 
• 769-92-6 4-tert-Butylaniline 
• 106-38-7 para-bromotoluene 
• 123324-87-8 4-tert-butyl-N-(4-methylphenyl)aniline 

Relevant academic research and scientific papers

THERANOSTIC AGENTS

A theranostic agent can be used in both photoacoustic imaging (PAI) and photothermal therapy (PTT) applications. The theranostic agent can include a small molecule, organic compound with absorption in the near-infrared (NIR) interrogation window (700-900 nm). The compound can be a biocompatible organic nanoparticle (ONP). The theranostic agent can be effectively used in PAI and PAI-guided PTT applications. The theranostic agent can be administered to a patient to locate a tumor site in the patient using invivo imaging techniques. Once the tumor site has been determined, the tumor site can be irradiated with near-infrared light to stop or inhibit the growth of the tumor.

Visible and near-infrared chemosensor for colorimetric and ratiometric detection of cyanide

A chemosensor system has been developed for rapid and selective detection of cyanide. The sensory molecules have the donor-acceptor type of structure and are designed by tuning the LUMO level or their reactivity towards cyanide. This sensory system is able to selectively distinguish cyanide among fluoride and many other anions at micromolar concentrations and instantly detect cyanide at ambient temperatures with a detection limit down to 1.0 M. Multiple sensory signals are available and can be used for both qualitative monitoring and quantitative determination of cyanide, including high-contrast visual color change, fluorescence quenching and enhancement in the visible and near-infrared spectral regions. The Royal Society of Chemistry 2009.